Nándor Szegedi

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 178 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study

Markus Zabel, Rik Willems, Andrzej Lubiński et al. · European Heart Journal · 2020 · 154 citations · Full text

Medicine, Cardiology, Cardiothoracic Surgery +13

Posterior Left Atrial Adipose Tissue Attenuation Assessed by Computed Tomography and Recurrence of Atrial Fibrillation After Catheter Ablation

Mohammed El Mahdiui, Judit Simon, Jeff M. Smit et al. · Circulation Arrhythmia and Electrophysiology · 2021 · 72 citations · Full text

Medicine, Cardiology, Radiology +14

Repeat procedure is a new independent predictor of complications of atrial fibrillation ablation

Nándor Szegedi, Gábor Széplaki, Szilvia Herczeg et al. · EP Europace · 2019 · 49 citations · Full text

Medicine, Cardiology, Surgery +17

Left atrial appendage size is a marker of atrial fibrillation recurrence after radiofrequency catheter ablation in patients with persistent atrial fibrillation

Judit Simon, Mohammed El Mahdiui, Jeff M. Smit et al. · Clinical Cardiology · 2021 · 34 citations · Full text

Medicine, Cardiology, Radiology +13